Table 1.
25OHD, ng/mL |
P Value | |||
---|---|---|---|---|
<20 | 20–29 | ≥30 | ||
n | 19 | 35 | 46 | |
Age, y | 56.6 ± 2.7 | 58.5 ± 2.0 | 66.8 ± 1.7a,b | .0009 |
Females, n/% | 14/17.7 | 25/31.7 | 40/50.6 | .19 |
Postmenopausal women, n/% | 10/71.4 | 20/80.0 | 40/100 | <.01 |
Age at menopause, y | 47.6 ± 2.2 | 49.0 ± 1.5 | 50.9 ± 1.1 | .33 |
Height, cm | 166.4 ± 2.0 | 165.9 ± 1.5 | 162.6 ± 1.3 | .17 |
Weight, kg | 83.3 ± 4.4 | 79.2 ± 3.2 | 71.1 ± 2.8c | .04 |
BMI, kg/m2 | 29.5 ± 1.4 | 28.7 ± 1.0 | 26.8 ± 0.9 | .16 |
White, n/% | 14/87.5 | 30/85.7 | 42/93.3 | .58 |
Hispanic, n/% | 5/26.3 | 5/14.3 | 7/15.2 | .48 |
PHPT duration, y | 3.0 ± 1.4 | 3.6 ± 1.0 | 5.2 ± 0.9 | .30 |
Meets surgical guidelines, n/% | 16/84.2 | 20/57.1 | 33/71.7 | .10 |
Calcium intake, mg/d | 867 ± 185 | 1033 ± 139 | 1197 ± 119 | .31 |
Taking vitamin D supplements, n/% | 5/26.3 | 21/60.0 | 39/84.8 | <.0001 |
Daily supplement use, IU/d | 711 ± 631 | 1056 ± 308 | 2059 ± 226c,d | .01 |
Current tobacco use, n/% | 1/5.3 | 1/2.9 | 4/8.7 | .83 |
Sun exposure score | 8.3 ± 1.4 | 8.5 ± 1.0 | 9.1 ± 0.9 | .84 |
Data are expressed as means ± SEM, unless stated otherwise.
P < .01 compared to 25OHD <20 ng/mL.
P < .01 compared to 25OHD 20–29 ng/mL.
P < .05 compared to 25OHD <20 ng/mL.
P < .05 compared to 25OHD 20–29 ng/mL.